News | February 24, 2022
Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
100% efficacy against severe Covid-19 disease and hospitalizations
100% efficacy against severe Covid-19 disease and hospitalizations
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
he financing was significantly oversubscribed with high demand from both existing and new investors.
Subscribe To Our Newsletter & Stay Updated
